Atlas Trials

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

Clinical trial NCT01341782 · COMPLETED

Trial details

NCT number
NCT01341782
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary HyperparathyroidismHemodialysis
Start date
2011-05-01
Primary completion
2012-04-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.